Literature DB >> 18055939

Impairment of self-monitoring: part of the endophenotypic risk for psychosis.

Dagmar Versmissen1, Inez Myin-Germeys, Ilse Janssen, Nicolas Franck, Nicolas Georgieff, Joost a Campo, Ron Mengelers, Jim van Os, Lydia Krabbendam.   

Abstract

BACKGROUND: A disorder of self-monitoring may underlie the positive symptoms of psychosis. The cognitive mechanisms associated with these symptoms may also be detectable in individuals at risk of psychosis. AIMS: To investigate (a) whether patients with psychosis show impaired self-monitoring, (b) to what degree this is associated with positive symptoms, and (c) whether this is associated with liability to psychotic symptoms.
METHOD: The sample included: individuals with a lifetime history of non-affective psychosis (n=37), a genetically defined risk group (n=41), a psychometrically defined risk group (n=40), and control group (n=49). All participants carried out an action-recognition task.
RESULTS: Number of action-recognition errors was associated with psychosis risk (OR linear trend over 3 levels:1.12, 95% CI1.04-1.20) and differential error rate was associated with the degree of delusional ideation in a dose-response fashion (OR linear trend over 3 levels:1.13, 95% CI1.00-1.26).
CONCLUSIONS: Alterations in self-monitoring are associated with psychosis with evidence of specificity for delusional ideation. In the risk state, this is expressed more as failure to recognise self-generated actions, whereas in illness failure to recognise alien sources come to the fore.

Entities:  

Mesh:

Year:  2007        PMID: 18055939     DOI: 10.1192/bjp.191.51.s58

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  1 in total

1.  "To see or not to see: that is the question." The "Protection-Against-Schizophrenia" (PaSZ) model: evidence from congenital blindness and visuo-cognitive aberrations.

Authors:  Steffen Landgraf; Michael Osterheider
Journal:  Front Psychol       Date:  2013-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.